Cargando…
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus
AIMS/HYPOTHESIS: People with diabetes have an increased cardiovascular risk with an accelerated development of atherosclerosis and an elevated mortality rate after myocardial infarction. Therefore, cardioprotective effects of glucose-lowering therapies are of major importance for the pharmacotherapy...
Autores principales: | Kohlmorgen, Christina, Gerfer, Stephen, Feldmann, Kathrin, Twarock, Sören, Hartwig, Sonja, Lehr, Stefan, Klier, Meike, Krüger, Irena, Helten, Carolin, Keul, Petra, Kahl, Sabine, Polzin, Amin, Elvers, Margitta, Flögel, Ulrich, Kelm, Malte, Levkau, Bodo, Roden, Michael, Fischer, Jens W., Grandoch, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245397/ https://www.ncbi.nlm.nih.gov/pubmed/34131781 http://dx.doi.org/10.1007/s00125-021-05498-0 |
Ejemplares similares
-
S1P Lyase Inhibition Starting After Ischemia/Reperfusion Improves Postischemic Cardiac Remodeling
por: Polzin, Amin, et al.
Publicado: (2022) -
Rivaroxaban attenuates neutrophil maturation in the bone marrow niche
por: Schneckmann, R., et al.
Publicado: (2023) -
Sphingosine‐1‐phosphate improves outcome of no‐reflow acute myocardial infarction via sphingosine‐1‐phosphate receptor 1
por: Polzin, Amin, et al.
Publicado: (2022) -
Multi-targeted (1)H/(19)F MRI unmasks specific danger patterns for emerging cardiovascular disorders
por: Flögel, Ulrich, et al.
Publicado: (2021) -
The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner
por: Hoermann, Henrike, et al.
Publicado: (2021)